FDA inspection
Endoceutics Pharma Inc.: FDA inspection ending Sep 20, 2012
FDA inspection 801935 · Administrative/Directed Change (ADC) · Mont-Saint-Hilaire
Key facts
| Inspection ID | 801935 |
|---|---|
| Firm | Endoceutics Pharma Inc. |
| FEI number | 3003082936 |
| Address | 597 Sir-Wilfrid-Laurier Blvd |
| City | Mont-Saint-Hilaire |
| Fiscal year | 2012 |
| Inspection end date | Sep 20, 2012 |
| Classification | Administrative/Directed Change (ADC) |
| Project area | Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data